Browsing Search Results

Matched Description: and many gram-negative organisms. It acts by inhibiting the dihydropteroate synthase, an important … effects of this treatment include itching, burning, redness, and swelling. Long-term use of this drug may result in cancer of the thyroid gland.

Matched Description: a longer duration and may require less frequent dosing. This can result in a more sustained effect … respiratory smooth muscle cells, vascular endothelial cells, the gastrointestinal tract, and immune cells

Matched Description: can enter the systemic cirulation, and most of GLP-1 are degraded by dipeptidyl peptidase-4

Matched Description: Apomorphine is a non-ergoline dopamine agonist with high binding affinity to dopamine D2, D3, and

Matched Description: interferes with the initiation of protein synthesis and with proper protein elongation. This eventually leads to bacterial cell death.

Matched Description: that degrades fibrin clots. In addition to its binding and activation on fibrin clots, PLG also … present in humans - type I plasminogen contains two glycosylation moieties (N-linked to N289 and O … , including tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and … urokinase plasminogen activator. The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562.

Matched Description: that degrades fibrin clots. In addition to its binding and activation on fibrin clots, PLG also … present in humans - type I plasminogen contains two glycosylation moieties (N-linked to N289 and O … , including tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and … urokinase plasminogen activator. The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562.

Matched Description: concentrations of serotonin in the synaptic cleft and reverses the state of low concentration seen in … ). CREB-1 enters the nucleus and affects transcription of brain-derived neurotrophic factor (BDNF). BDNF

Matched Description: Irinotecan, branded as Camptosar, Campto, Onivyde and others, is a cancer medication used to treat … colon and small cell lung cancers, alone or with other drugs. Irinotecan can be processed by the

Matched Description: . Sexual stimulation causes the release of nitric oxide (NO) from nerves and endothelial cells into the … concentration of cGMP, increasing the vasodilation and improving blood flow leading to penile erection.